• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶(MMP)和尿激酶型纤溶酶原激活剂(uPA)系统的差异表达及其在食管鳞状细胞癌中的表达与预后的相关性

Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.

作者信息

Yamashita Keishi, Tanaka Yoichi, Mimori Koshi, Inoue Hiroshi, Mori Masaki

机构信息

Department of Surgical Oncology, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan.

出版信息

Int J Cancer. 2004 Jun 10;110(2):201-7. doi: 10.1002/ijc.20067.

DOI:10.1002/ijc.20067
PMID:15069682
Abstract

Matrix metalloproteinase (MMP) is critical for carcinoma progression. In our study, we evaluated the prognostic significance of the major MMP family such as MMP-3, MMP-9, MMP-11 and MT1-MMP at the mRNA in 44 esophageal squamous cell carcinoma (ESCC) that were previously characterized for MMP-7, MMP-1 and MMP-2, and their relation to urokinase system (uPA and uPAR). MT1-MMP, MMP-11 and MMP-2 expressions are closely associated with each other, while MMP-9 and uPAR expressions are inversely associated with the former group. There is no MMP related to clinicopathological factors; however, patients with high MT1-MMP could show worse prognosis, as compared to those with low MT1-MMP expression (p=0.01), as well as MMP-11 did (p=0.02). Both MMP showed clear expression of carcinoma cells by immunohistochemistry. In patients with high MT1-MMP, recurrence was more prominent (23/26: 88.5%) than those with low MT1-MMP (7/18: 38.9%) (p=0.0016). In the 20 cases who died within 3 years, all 15 cases with high MT1-MMP showed initial recurrence of distant metastasis, and the other 5 cases with low MT1-MMP showed locoregional recurrence (p=0.000064). These results could indicate that there is a relevant mechanism of associated expression of clinically significant MMP and that among them, MT1-MMP plays the most critical role in ESCC progression.

摘要

基质金属蛋白酶(MMP)对癌症进展至关重要。在我们的研究中,我们评估了主要MMP家族(如MMP - 3、MMP - 9、MMP - 11和MT1 - MMP)在44例食管鳞状细胞癌(ESCC)中的mRNA水平的预后意义,这些病例之前已对MMP - 7、MMP - 1和MMP - 2进行了特征分析,以及它们与尿激酶系统(uPA和uPAR)的关系。MT1 - MMP、MMP - 11和MMP - 2的表达彼此密切相关,而MMP - 9和uPAR的表达与前一组呈负相关。没有MMP与临床病理因素相关;然而,与MT1 - MMP低表达的患者相比,MT1 - MMP高表达的患者预后可能更差(p = 0.01),MMP - 11也是如此(p = 0.02)。通过免疫组织化学,两种MMP在癌细胞中均显示出清晰的表达。MT1 - MMP高表达的患者复发比MT1 - MMP低表达的患者更显著(23/26:88.5%)(7/18:38.9%)(p = 0.0016)。在3年内死亡的20例患者中,15例MT1 - MMP高表达的患者均出现远处转移的初始复发,另外5例MT1 - MMP低表达的患者出现局部区域复发(p = 0.000064)。这些结果可能表明存在临床上重要的MMP相关表达的相关机制,其中MT1 - MMP在ESCC进展中起最关键的作用。

相似文献

1
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.基质金属蛋白酶(MMP)和尿激酶型纤溶酶原激活剂(uPA)系统的差异表达及其在食管鳞状细胞癌中的表达与预后的相关性
Int J Cancer. 2004 Jun 10;110(2):201-7. doi: 10.1002/ijc.20067.
2
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.基质金属蛋白酶7、9及膜型1基质金属蛋白酶在食管鳞状细胞癌中的表达增加。
Cancer. 2000 May 15;88(10):2201-9.
3
Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.膜型1基质金属蛋白酶和基质金属蛋白酶-2在人头颈部鳞状细胞癌中表达的临床意义
Hum Pathol. 2000 Aug;31(8):895-904. doi: 10.1053/hupa.2000.9756.
4
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.基质金属蛋白酶(MMP)-2、MMP-9及膜型1-MMP在肝细胞癌和胰腺腺癌中的差异表达:对肿瘤进展及临床预后的影响
Clin Cancer Res. 2000 Jul;6(7):2726-34.
5
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.基质金属蛋白酶(MMP - 2、MMP - 9、MT1 - MMP)及其抑制剂(TIMP - 1、TIMP - 2)在卵巢常见上皮性肿瘤中的表达
Int J Oncol. 2000 Oct;17(4):673-81.
6
Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo.成纤维细胞衍生的MT1-MMP在体外和体内均促进肿瘤进展。
BMC Cancer. 2006 Mar 6;6:52. doi: 10.1186/1471-2407-6-52.
7
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.基质金属蛋白酶在早期口腔鳞状细胞癌中的表达作为肿瘤转移和预后的预测指标。
Clin Cancer Res. 2004 Jan 15;10(2):634-40. doi: 10.1158/1078-0432.ccr-0864-02.
8
Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.基质金属蛋白酶-2和金属蛋白酶组织抑制剂-2在膀胱癌中的表达的预后价值
Cancer. 1998 Apr 1;82(7):1359-66.
9
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.基质溶素-2(MMP-26)表达与食管鳞状细胞癌肿瘤进展及MMP-9激活的相关性
Carcinogenesis. 2004 Dec;25(12):2353-60. doi: 10.1093/carcin/bgh270. Epub 2004 Aug 27.
10
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.基质金属蛋白酶-7(MMP-7)和膜型基质金属蛋白酶-1(MT1-MMP)在口腔鳞状细胞癌中的表达作为肿瘤侵袭和预后的预测指标
J Oral Pathol Med. 2007 Aug;36(7):415-24. doi: 10.1111/j.1600-0714.2007.00546.x.

引用本文的文献

1
The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities.尿激酶受体(uPAR)作为靶向癌症治疗中的“特洛伊木马”:挑战与机遇
Cancers (Basel). 2021 Oct 27;13(21):5376. doi: 10.3390/cancers13215376.
2
Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma.食管鳞状细胞癌差异表达基因与免疫细胞浸润特征的综合生物信息学分析。
Sci Rep. 2021 Aug 17;11(1):16696. doi: 10.1038/s41598-021-96274-y.
3
MicroRNA‑212 facilitates the motility and invasiveness of esophageal squamous carcinoma cells.
微小 RNA-212 促进食管鳞癌细胞的迁移和侵袭。
Mol Med Rep. 2019 Oct;20(4):3633-3641. doi: 10.3892/mmr.2019.10647. Epub 2019 Sep 3.
4
High expression of uPA related to p38MAPK in esophageal cancer indicates poor prognosis.食管癌中与p38丝裂原活化蛋白激酶相关的尿激酶型纤溶酶原激活物高表达提示预后不良。
Onco Targets Ther. 2018 Nov 29;11:8427-8434. doi: 10.2147/OTT.S181701. eCollection 2018.
5
Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses.膜型1基质金属蛋白酶诱导食管鳞状细胞癌上皮-间质转化:临床及体外分析观察
Sci Rep. 2016 Feb 26;6:22179. doi: 10.1038/srep22179.
6
Extra- and intracellular imaging of human matrix metalloprotease 11 (hMMP-11) with a cell-penetrating FRET substrate.利用穿透细胞的 FRET 底物对人基质金属蛋白酶 11(hMMP-11)进行细胞内外成像。
J Biol Chem. 2012 Nov 2;287(45):37857-67. doi: 10.1074/jbc.M112.371500. Epub 2012 Aug 27.
7
Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.基质金属蛋白酶-1/蛋白酶激活受体-1 信号轴在肝细胞癌中的预后价值。
Pathol Oncol Res. 2012 Apr;18(2):397-403. doi: 10.1007/s12253-011-9458-8. Epub 2011 Sep 10.
8
RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.RNA干扰介导靶向IOMM-lee恶性脑膜瘤细胞系中的尿激酶型纤溶酶原激活物受体和基质金属蛋白酶-9基因表达可抑制肿瘤生长、肿瘤细胞侵袭和血管生成。
Int J Oncol. 2007 Jul;31(1):5-17.
9
Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells.神经母细胞瘤细胞对电离辐射的反应:对人微血管内皮细胞体外侵袭和血管生成的调节
Int J Oncol. 2006 Dec;29(6):1525-31.
10
Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface.尿激酶型纤溶酶原激活剂(uPA)介导的细胞表面蛋白水解过程对TNF前体药物的靶向选择性激活。
Cancer Immunol Immunother. 2006 Dec;55(12):1590-600. doi: 10.1007/s00262-006-0162-6. Epub 2006 Apr 25.